Scinovex
review Open AccessTop 1% cited

Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

Mayo Clinic Proceedings · 2010 · Vol. 85(3) · pp. S3–S14
Robert H. DworkinAlec O'connorJoseph AudetteRalf BaronGeoffrey K. GourlayMaija HaanpääJoel L. KentElliot J. KraneAlyssa LebelRobert M. LevySean MackeyJohn M. MayerChristine MiaskowskiSrinivasa N. RajaAndrew S.C. RiceKenneth E. SchmaderBrett R. StaceySteven P. StanosRolf‐Detlef TreedeDennis C. TurkGary A. WalcoChristopher Wells
Pain Mechanisms and TreatmentsPain Management and Opioid UseAnesthesia and Pain ManagementMedicineNeuropathic painGabapentinPregabalinOxcarbazepineLacosamideClinical trialTramadolCarbamazepineAnesthesia

MeSH terms

PregabalinGabapentinLacosamideAcetamidesAminesAnalgesicsAnalgesics, OpioidAnesthetics, LocalAntidepressive AgentsCyclohexanecarboxylic Acidsgamma-Aminobutyric AcidHumansNeuralgiaRandomized Controlled Trials as TopicSelective Serotonin Reuptake Inhibitors

Funding

  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Purdue University
  • University of Rochester
  • Boston Scientific Corporation
  • Purdue Pharma
Citations
1,316
FWCI
61.01
field-weighted impact
References
106
Percentile
100%
vs. same field & year
Citations per year
Cited by
Ketamine for chronic pain: risks and benefits
British Journal of Clinical Pharmacology · 2013 · 486 citations
Importance of glial activation in neuropathic pain
European Journal of Pharmacology · 2013 · 457 citations
Diabetic neuropathy: clinical manifestations and current treatments
The Lancet Neurology · 2012 · 1,148 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.